ArticleAsian Pacific journal of cancer prevention : APJCP2025
Isolation of Protein and Peptides from Symbiont Bacteria of Green Algae, Caulerpa lentillifera and Their Potency as Anticancer.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAlgae contain many symbiotic bacteria, often considered pollutants in algal cultivation. Recent studies indicate that these connections enhance the longevity of both organisms. Researching the bioactive metabolites of marine bacteria has emerged as a promising strategy for drug discovery. Green algae, including Caulerpa lentillifera, have anticancer activity and possess antioxidant qualities. The research emphasizes the isolation and identification of beneficial proteins from symbiotic bacteria, particularly Caulerpa lentillifera.
methodsThe stages of the research included isolation and identification of the endophytic bacteria of the green alga symbiont C. lentillifera, isolation of protein from the bacterial symbiont, fractionation, hydrolysis, ultrafiltration of protein into peptides, and testing for activity. Screening activities used the BSLT to obtain the value of LC50, and the mitotic test of the sea urchin zygote cell Tripneustes gratilla Linn to find the value of IC50.
resultsThe results of this study indicated that the bacterial symbiont of the algae C. lentillifera was a species of Cobetia marina strain CL2-2. The peptide with molecular weight < 3 kDa from Cobetia marina strain CL2-2 was active. The peptide was from protein deposited with 40-60% saturated ammonium sulfate and hydrolyzed using pepsin enzyme. BSLT toxicity tests indicate that peptides with a molecular weight of less than 3 kDa showed significant toxicity, indicated by an LC50 value of 4.061 ppm. In a mitotic cytotoxicity test involving sea urchin zygote cells, peptides with a molecular weight of less than 3 kDa indicated significant cytotoxic activity, resulting in an IC50 value of 7.236 μg/mL.
conclusionThe bioactive peptide with molecular weight of less than 3 kDa resulting from protein hydrolysis isolated from the green algae symbiont C. lentillifera has the potential as an anticancer agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.